FDA Approves First Medication for Obstructive Sleep Apnea
🔵 The U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used in combination with a reduced-calorie diet and increased physical activity. ” This approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said … Read more